NCT02059915View on ClinicalTrials.gov

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation X, single dose, under fed conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation K, single dose, under fed conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation X, single dose, under fasting conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation K, single dose, under fasting conditions

Trial Locations (1)

55114

Pfizer Investigational Site, Saint Paul

Sponsors

Lead Sponsor

Pain Therapeutics
All Listed Sponsors
lead

Pain Therapeutics

INDUSTRY